SCHEMBL264768

SCHEMBL264768

Cc1cc(C(=O)O)ccc1[N+](=O)[O-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 1.00
CASP6 P55212 1/20 0.70
MAPT P10636 3/20 0.61
ALDH1A1 P00352 2/20 0.61
LMNA P02545 1/20 0.59
HCAR3 P49019 5/20 0.58
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
GAA P10253 1/20 0.57
POLB P06746 2/20 0.56
KDM4E B2RXH2 1/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CES2 O00748 1/20 0.53
CES1 P23141 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11553659 0.98 TSHR (0.96) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL27455525 0.98 TSHR (0.96) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL9315175 0.92 TSHR (0.84) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL28050912 0.87 TSHR (0.77) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL7339887 0.85 TSHR (0.73) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL28067032 0.85 TSHR (0.73) TSHRCASP6MAPTALDH1A1HCAR3
Phenylhydrazine SCHEMBL11673197 0.85 TSHR (0.73) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL1026131 0.85 TSHR (0.74) TSHRMAPTALDH1A1LMNAMEN1
SCHEMBL177231 0.85 TSHR (1.00) TSHRCASP6MAPTALDH1A1LMNA
SCHEMBL30668892 0.85 TSHR (1.00) TSHRCASP6MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 988 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120192230-A Method for treating nitrobenzoic acid mixture as byproduct of 3-methyl-2-nitrobenzoic acid 南昌大学 2025-06-24 CN claimed
CN-119192006-B Method for preparing 3-methyl-4-aminobenzoic acid by catalytic hydrogenation 河南羲和化工科技有限公司 2025-06-03 CN claimed
CN-119192006-A Method for preparing 3-methyl-4-aminobenzoic acid by catalytic hydrogenation 河南羲和化工科技有限公司 2024-12-27 CN claimed
CN-119080334-A Comprehensive utilization method of nitric acid containing organic matters 山东友道化学有限公司 2024-12-06 CN claimed
CN-118344743-B High-viscosity modified asphalt and preparation method thereof 南京航空航天大学 2024-11-26 CN claimed
CN-116283598-B Method for preparing 3-methyl-4-nitrobenzoic acid by nitric acid continuous oxidation 浙江科技学院 2024-11-19 CN claimed
CN-114835584-B Method for post-treatment of esterification reaction of 3-methyl-4-nitrobenzoic acid and alcohol 浙江金立源药业有限公司 2024-08-09 CN claimed
CN-118388359-A Preparation method of ethyl 5-methyl-2-aminobenzoate 江西大宇医药股份有限公司 2024-07-26 CN claimed
CN-118344743-A High-viscosity modified asphalt and preparation method thereof 南京航空航天大学 2024-07-16 CN claimed
CN-116462591-B Synthesis method of 3-methyl-4-nitrobenzoic acid 安徽江泰新材料科技有限公司 2024-06-11 CN claimed
CN-101271769-A Neutral electrolyte for a wet electrolytic capacitor AVX CORP (US) 2008-09-24 CN claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US claimed
CN-1935376-A Catalyst and its use for synthesizing 4-nitro-3-methyl benzoic acid UNIV ZHENGZHOU (CN) 2007-03-28 CN claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
US-4005145-A ISOMERIZATION OF A,B-UNSATURATED OXO COMPOUNDS TO B,G-ISOMER HOFFMANN-LA ROCHE INC. (US) 1977-01-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 TSHR 2894/4885CASP6 2660/4885MAPT 4074/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 TSHR 4082/4885CASP6 2761/4885MAPT 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.